iNCOVACC- Could this New Tool be the Answer to COVID?
The iNCOVACC has been received emergency use approval as a heterologous booster shot for individuals above 18 years of age. This move comes 3 months a…
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.